Ingmar Hoerr

Ingmar Hoerr
Ingmar Hoerr at the TV-talkshow "Nachtcafe" of SWR
Born1968 (age 55–56)
Neckarsulm, Germany
EducationUniversity of Tübingen
Occupation(s)Founder and CEO of CureVac
Founder of CureVac (from left):Prof. H.G. Rammensee; Ingmar Hoerr; Steve Pascolo; Florian von der Mülben; Prof. G. Jung.

Ingmar Malte Hoerr (born 1968 in Neckarsulm) is a German biologist. He pioneered vaccinology research concerning the use of RNA and is a founder of the German biotechnology company CureVac. He created the initial technology used in RNA vaccines and has reportedly been nominated for a Nobel Prize.[1] He is currently an Ambassador for the European Innovation Council for the years 2021–2027.[2]

  1. ^ Miller, Joe (23 February 2021). "How vaccine laggard CureVac hopes to come out on top". Financial Times.
  2. ^ "EIC Ambassadors (2021 – 2027)". European Innovation Council. Retrieved 31 July 2022.